• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2020 年 5 月,日本非流行地区医疗机构工作人员中 SARS-CoV-2 抗体的血清流行率:一项基于医院的研究。

Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers in a nonepidemic region, Japan: A hospital-based study on May, 2020.

机构信息

Department of Cardiology, Iwate Prefectural Central Hospital, Morioka, Iwate, Japan.

Department of Clinical Laboratory, Iwate Prefectural Central Hospital, Morioka, Iwate, Japan.

出版信息

J Med Virol. 2021 Jul;93(7):4608-4611. doi: 10.1002/jmv.26962. Epub 2021 Apr 3.

DOI:10.1002/jmv.26962
PMID:33760273
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8250612/
Abstract

The polymerase chain reaction (PCR) testing rate is low in our local area and the true rate of coronavirus disease 2019 (COVID-19) infection may include many asymptomatic individuals. We conducted a serosurveillance using antibody testing in an area where official report of COVID-19 infection is not done yet. Blood samples were obtained from 1404 healthcare workers (41 ± 11 years) in our hospital on May 29-31, 2020. First, the potential infection frequency was confirmed using two quantitative antibody tests. In addition, the usefulness of rapid antibody kit testing for COVID-19 serosurveillance was examined. A COVID-19-indected case was defined as showing positive results in both quantitative tests. None of 1404 samples had positive results from the two quantitative tests. The false positive rates were 0.36% and 0.07%, whereas those in rapid antibody kits were 3.3% and 3.0%. In conclusion, as of May, 2020, potential spread mainly by asymptomatic individuals infected with COVID-19 was not found in our local area where there was no official report of COVID-19, even if the PCR testing rate was low. Rapid antibody kits might not be useful due to the high false positive rate in an area with a low incidence of COVID-19 infected individuals.

摘要

聚合酶链反应(PCR)检测率在我们当地较低,而 2019 年冠状病毒病(COVID-19)的真实感染率可能包括许多无症状个体。我们在尚未报告 COVID-19 感染的地区进行了血清学监测,使用抗体检测。2020 年 5 月 29 日至 31 日,从我们医院的 1404 名医护人员(41±11 岁)中采集了血样。首先,使用两种定量抗体检测方法确认了潜在的感染频率。此外,还检查了快速抗体试剂盒检测在 COVID-19 血清学监测中的有用性。COVID-19 感染病例的定义是两种定量检测均呈阳性。在 1404 个样本中,没有一个样本在两种定量检测中呈阳性。假阳性率分别为 0.36%和 0.07%,而快速抗体试剂盒的假阳性率分别为 3.3%和 3.0%。总之,截至 2020 年 5 月,在尚未报告 COVID-19 的当地地区,未发现主要由无症状个体传播的 COVID-19,尽管 PCR 检测率较低。由于 COVID-19 感染个体发病率较低的地区假阳性率较高,快速抗体试剂盒可能用处不大。

相似文献

1
Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers in a nonepidemic region, Japan: A hospital-based study on May, 2020.2020 年 5 月,日本非流行地区医疗机构工作人员中 SARS-CoV-2 抗体的血清流行率:一项基于医院的研究。
J Med Virol. 2021 Jul;93(7):4608-4611. doi: 10.1002/jmv.26962. Epub 2021 Apr 3.
2
Orthogonal antibody testing for COVID-19 among healthcare workers in a non-epidemic place and time:Japan's Iwate Prefecture, May 18-31, 2020.2020 年 5 月 18 日至 31 日,非流行时期和地点的医护人员中的 COVID-19 正交抗体检测:日本岩手县。
Fukushima J Med Sci. 2021 Apr 10;67(1):27-32. doi: 10.5387/fms.2020-21. Epub 2021 Feb 26.
3
The seroprevalence of SARS-CoV-2 in a rural southwest community.农村西南社区 SARS-CoV-2 的血清阳性率。
J Osteopath Med. 2021 Feb 1;121(2):199-210. doi: 10.1515/jom-2020-0287.
4
Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020.2020 年 6 月日本 SARS-CoV-2 特异性抗体流行情况。
Emerg Infect Dis. 2021 Feb;27(2):628-631. doi: 10.3201/eid2702.204088.
5
Prevalence of SARS-CoV-2 antibodies in health care personnel of two acute care hospitals in Linz, Austria.奥地利林茨两家急症医院医护人员中新冠病毒2型抗体的流行情况。
Clin Chem Lab Med. 2021 Jan 11;59(6):e231-e234. doi: 10.1515/cclm-2020-1681. Print 2021 May 26.
6
Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure.不同程度接触 2019 年冠状病毒病(COVID-19)患者的医护人员中严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)抗体的血清阳性率。
Infect Control Hosp Epidemiol. 2020 Dec;41(12):1441-1442. doi: 10.1017/ice.2020.390. Epub 2020 Aug 3.
7
Seroprevalence of SARS-CoV-2 antibody among healthcare workers in a university hospital in Mallorca, Spain, during the first wave of the COVID-19 pandemic.西班牙马略卡岛一家大学医院医护人员在 COVID-19 大流行第一波期间 SARS-CoV-2 抗体血清阳性率。
Int J Infect Dis. 2021 Apr;105:482-486. doi: 10.1016/j.ijid.2021.02.104. Epub 2021 Feb 27.
8
Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.在 2019 年冠状病毒病疫情后,对一个经过全面 PCR 检测的社区使用六种不同血清学检测方法进行抗体反应的研究——CoNAN 研究。
Clin Microbiol Infect. 2021 Mar;27(3):470.e1-470.e9. doi: 10.1016/j.cmi.2020.11.009. Epub 2020 Nov 20.
9
Prevalence of Anti-SARS-CoV-2 Specific Antibodies in Health-Care Workers Compared to General Population during an Early Phase of the Pandemic, Tehran-Iran.伊朗德黑兰:大流行早期医护人员与普通人群抗 SARS-CoV-2 特异性抗体的流行率比较。
Iran J Immunol. 2021 Mar;18(1):82-92. doi: 10.22034/iji.2021.88168.1851.
10
Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.用 SARS-CoV-2 IgG-IgM 抗体快速检测试剂盒检测来自欧洲和非洲的大流行前血标本时,出现了出乎意料的高频率非特异性反应,这表明 IgM 是“阿喀琉斯之踵”。
J Med Virol. 2021 Apr;93(4):2196-2203. doi: 10.1002/jmv.26628. Epub 2020 Nov 22.

引用本文的文献

1
COVID-19 infection and seroconversion rates in healthcare workers in Lebanon: An observational study.黎巴嫩医护人员中 COVID-19 感染和血清转化率的观察性研究。
Medicine (Baltimore). 2023 Apr 25;102(17):e32992. doi: 10.1097/MD.0000000000032992.
2
Low prevalence of SARS-CoV-2 specific antibodies among endoscopists and their assistants in a university hospital in Tochigi prefecture-A single-center study.栃木县某大学医院内镜医师及其助手体内SARS-CoV-2特异性抗体的低流行率——一项单中心研究
DEN Open. 2021 Dec 3;2(1):e79. doi: 10.1002/deo2.79. eCollection 2022 Apr.

本文引用的文献

1
Seroprevalence of Anti-SARS-CoV-2 Antibodies among Outpatients in Southwestern Seoul, Korea.韩国首尔西南部门诊患者中抗 SARS-CoV-2 抗体的血清阳性率。
J Korean Med Sci. 2020 Aug 24;35(33):e311. doi: 10.3346/jkms.2020.35.e311.
2
Disappearance of antibodies to SARS-CoV-2 in a -COVID-19 patient after recovery.一名新冠康复患者体内新冠病毒抗体消失。
Clin Microbiol Infect. 2020 Dec;26(12):1703-1705. doi: 10.1016/j.cmi.2020.07.009. Epub 2020 Jul 9.
3
Antibody responses against SARS-CoV-2 in COVID-19 patients.COVID-19患者针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的抗体反应。
J Med Virol. 2021 Jan;93(1):144-148. doi: 10.1002/jmv.26241. Epub 2020 Aug 2.
4
Challenges of community point-of-care antibody testing for COVID-19 herd-immunity in Japan.日本针对新冠病毒群体免疫开展社区即时抗体检测的挑战。
QJM. 2020 Nov 1;113(11):785-786. doi: 10.1093/qjmed/hcaa182.
5
Antibody Testing for COVID-19.新型冠状病毒肺炎的抗体检测
Am J Clin Pathol. 2020 Jun 8;154(1):1-3. doi: 10.1093/ajcp/aqaa082.
6
World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19).世界卫生组织宣布全球紧急状态:对 2019 年新型冠状病毒(COVID-19)的回顾。
Int J Surg. 2020 Apr;76:71-76. doi: 10.1016/j.ijsu.2020.02.034. Epub 2020 Feb 26.
7
Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV.新兴人类致病冠状病毒 SARS-CoV、MERS-CoV 和 2019-nCoV 的病理学和发病机制的重叠和离散方面。
J Med Virol. 2020 May;92(5):491-494. doi: 10.1002/jmv.25709. Epub 2020 Feb 21.
8
A new coronavirus associated with human respiratory disease in China.一种在中国与人类呼吸道疾病相关的新型冠状病毒。
Nature. 2020 Mar;579(7798):265-269. doi: 10.1038/s41586-020-2008-3. Epub 2020 Feb 3.